Rochester Arthritis & Joint Pain Center shares insights from a new article on non-surgical knee pain treatments and ...

Explore the unique aspects of rheumatoid arthritis in men, including diagnosis, symptoms, complications, and support options ...

Researchers at University College London (UCL) have uncovered a key mechanism that helps the body switch off inflammation – a ...

AbbVie’s lost exclusivity for Humira is offset by immunology and neurology sales, diversified by its emerging oncology ...

Researchers at University College London (UCL) have uncovered a key mechanism that helps the body switch off inflammation—a breakthrough that could lead to new treatments for chronic diseases ...

Artiva Biotherapeutics is developing NK cell immunotherapy for autoimmune disease. Early trial data in B-cell lymphoma ...

Combination therapy with ixekizumab and tirzepatide bested monotherapy with ixekizumab alone in both psoriatic arthritis and ...

A national cohort study shows rheumatoid arthritis remission rates in England and Wales have plateaued since 2018, with wide ...

Topline data were announced from a phase 3b trial evaluating the concomitant use of ixekizumab and tirzepatide in adults with active psoriatic arthritis and obesity.

You’re playing basketball and your knee twists wrong. Or maybe your shoulder won’t stop hurting after that climbing trip.

People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.

Treatment with biologic DMARDs vs standard therapy improved clinical response rates and flare outcomes among patients with polyarticular JIA.